Economic volatility and uncertainty is also making a significant impact on merger and acquisition activity in the diagnostics space.
Lab Industry Report
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Subscribe today for access to
Articles and Reports
The Miami-based startup has secured major in-home phlebotomy services contracts from some of the nation’s biggest lab companies.
Two lab staffing experts weigh in on current trends and what labs need to do to attract and retain talent in today’s environment.
A roundup of key mergers, acquisitions, and strategic asset purchases in the healthcare industry in September.
The Hilden, Germany-based company is extending its genetic testing profile beyond oncology to neurology biomarkers.
The agency recently stated that current testing capacity is adequate and established limits on its review of new EUA submissions.
ACLA and public health experts warn that current reimbursement rates will hamper US efforts to contain monkeypox spread.
Congress reportedly set to pass a stripped-down version of the FDA user fees bill without the VALID Act component regulating LDTs.
On August 21, the FDA proposed new guidelines on charging for investigational drugs; here are the key highlights.
Revised final rule essentially disarms the threat of insurers having the advantage in out-of-network price disputes.
While the overall M&A market has been slow in 2022, Labcorp has been on a bit of an acquisitions binge.